Table 2.
Resveratrol Concentration | Cell Line | Method/Target Molecule | Effect | Reference |
---|---|---|---|---|
10 mM—inside microcapsules | D407 RPE | ELISA | ↓ VEGF ↓ IL-6 |
[160] |
25, 50, and 100 μM | D407 RPE | The activity of antioxidant enzymes | ↑ SOD ↑ Catalase ↑ Reduced glutathione |
[153] |
12.5, 25, 50 and 100 mg/L | D407 RPE | ELISA Western Blotting qRT-PCR |
↑ SOD ↓ MDA ↑ Bcl-2 ↓ Caspase-3 |
[161] |
10 μM | ARPE-19 | SIRT1 Activity Assay Kit DNMT Activity Quantification Kit qRT-PCR |
↑ SIRT1 levels ↑ DNA methyltransferases (DNMTs) |
[162] |
10 μM | ARPE-19 | Flow cytometry Acridine orange staining |
↓ Cell death ↑ Autophagy |
[163] |
10 μM | ARPE-19 | ELISA | ↓ VEGF | [164] |
10 μM | ARPE-19 | ELISA | ↓ VEGF ↓ IL-6 ↓ IL-8 |
[142] |
10 μm 20 μM 50 μM |
ARPE-19 | ELISA Western blotting |
↓ VEGF | [143] |
50 μM 100 μM |
ARPE-19 | Western blotting | ↓ ERK 1/2 | [151] |
2–50 μM | ARPE-19 | ELISA RT-PCR |
↓ VEGF-A ↓ VEGF-C |
[144] |
40 μM | E1A.NR3 retinal cells | Western blotting | ↑ SIRT-1 ↑ Ku70 ↓ Bax |
[165] |
Pre-treatment for 24 h with 1 μM | HRECs | Carboxy-DCFDA | ↓ Intracellular ROS levels | [166] |
5 μM | HUVECs | Western blotting PCR |
↑ SIRT1 levels | [167] |
25 μM | Primary porcine trabecular meshwork cells | Carboxy-DCFDA RT-PCR Flow cytometry |
↓ Intracellular ROS levels ↓ IL1α, IL6, IL8, ↓ sa-β-gal and lipofuscin |
[155] |
2.5 μM, 5 μM, 10 μM and 20 μM | Human lens epithelial cells (HLEB-3) | WST-1 Flow cytometry Western blotting |
↑ Cell viability after H2O2 damage ↓ p38 and JNK phosphorylation ↑ SOD, Catalase and HO-1 expression |
[156] |
↑—Overexpression/Increased level; ↓—Down-regulation/Decreased level.